Overexpression of c-myb in Leukaemic and Non-Leukaemic Variants of Cutaneous T-Cell Lymphoma

Poenitz, N.; Simon-Ackermann, J.; Gratchev, A.; Qadoumi, M.; Klemke, C.-D.; Stadler, R.; Kremer, A.; Radenhausen, M.; Henke, U.; Assaf, C.; Utikal, J.; Goerdt, S.; Dippel, E.
September 2005
Dermatology (10188665);2005, Vol. 211 Issue 2, p84
Academic Journal
Background: The c-myb oncogene is a transcription factor that regulates proliferation, differentiation and apoptosis of haematopoietic cells and activated T cells by binding to promoter sequences of such genes as c-myc or bcl-2 that are expressed in cutaneous T-cell lymphoma (CTCL). Objective: Our study was performed in order to evaluate c-myb expression as a quantitative parameter for differential diagnosis in leukaemic and non-leukaemic variants of CTCL. Methods: c-myb expression was analysed in lesional skin and in the peripheral blood of 21 patients with mycosis fungoides (MF), 15 patients with Sézary syndrome (SS) and 15 patients with inflammatory skin diseases using immunohistochemistry and semiquantitative as well as quantitative RT-PCR. Results: Immunohistochemistry confirmed expression of c-myb in the lesional skin of the majority of CTCL patients with a tendency towards higher expression in SS (1.86 ± 0.5) versus MF (1.2 ± 0.7) while c-myb was absent from the lesional skin of patients with inflammatory skin diseases. c-myb was overexpressed in the peripheral blood in all SS patients (100% SS vs. 35.7% MF) at a high expression level (51,335.31 ± 31,960.32 AU in SS vs. 1,226.35 ± 1,258.29 AU in MF using semiquantitative RT-PCR, and 5.72 × 10–2 ± 2.27 × 10–2 in SS vs. 0.91 × 10–2 ± 1.18 × 10–2 in MF vs. 0.24 × 10–2 ± 0.11 × 10–2 in inflammatory skin disease using quantitative RT-PCR). CD4+ cells from the peripheral blood of SS patients and cell lines in vitro showed the highest c-myb expression levels upon quantitative RT-PCR (23.27 × 10–2 and 10.78 × 10–2 ± 7.24 × 10–2). Conclusion: Overexpression of c-myb in skin lesions of both non-leukaemic and leukaemic CTCL independent of the stage of the disease indicates that it acts early in disease development. Nevertheless, if positive, c-myb expression in lesional skin is a clear-cut diagnostic marker for CTCL as compared to inflammatory skin diseases. High-level expression of c-myb in the peripheral blood as assessed by quantitative RT-PCR constitutes an additional diagnostic parameter for SS and may be especially useful in cases in which morphological determination of Sézary cells or FACS analysis of CD7 and CD26 remain inconclusive. Copyright © 2005 S. Karger AG, Basel


Related Articles

  • Atypical Poorly Differentiated Cutaneous T-Cell Lymphoma with an Angiocentric Growth Pattern Presenting Histologically as Vasculitis. Laetsch, B.; Hofbauer, G.; Kempf, W.; Burg, G.; Dummer, R. // Dermatology (10188665);2005, Vol. 210 Issue 4, p341 

    We report the case of a 41-year-old patient with an aggressive cutaneous T-cell lymphoma (CTCL) initially presenting on histology as lymphocytic vasculitis. On repeated histological examination and by molecular biology work-up, the diagnosis of an unclassifiable CTCL could eventually be...

  • non-Hodgkin's lymphoma:. Huber, Jeffrey T.; Gillaspy, Mary L. // Encyclopedic Dictionary of AIDS-Related Terminology;2000, p162 

    A definition of the term non-Hodgkin's lymphoma is presented. It refers to a lymphoma other than Hodgkin's disease. Non-Hodgkin's lymphomas may be classified into nodular or diffuse tumor patterns and by cell type. They can be also be classified into high, intermediate, and low grade malignancy...

  • Lymphoma. Burns-Naas, Leigh Ann; Vohr, Hans-Werner // Encyclopedic Reference of Immunotoxicology;2005, p412 

    A definition of the term "Lymphoma" is presented. Lymphomas are diverse neoplasms that begin by the malignant transformation, usually of a T cell, B cell, or natural killer cell, in the lymphatic system. These diseases result from damage to the cell's DNA that results in uncontrolled and...

  • Comparison of Different Lymphoma Cell Purging Modalities: An Experimental Study with K422 Lymphoma Cells. Hundsdörfer; Fruehauf; Haberkorn; Höft; Haas; Zeller // Acta Haematologica;1999, Vol. 101 Issue 4, p185 

    Blood-derived autografts from patients with non-Hodgkin’s lymphoma (NHL) are frequently contaminated with clonogenic lymphoma cells. In order to obtain a more efficient lymphoma cell depletion from the transplants we compared the efficiency of different purging techniques: B-cell-directed...

  • Prognostic significance of t(14;18) and bcl-2 gene... Martinka, Magda; Comeau, Terry // Clinical & Investigative Medicine;Dec97, Vol. 20 Issue 6, p364 

    Evaluates whether there is an association between the presence of t(14;18) and bcl-2 gene expression in patients with follicular small cleaved cell lymphoma (FSCCL) and diffuse large cell lymphoma (DLCL). Materials and methods used; Clinical stage at diagnosis and t(14;18); Response to...

  • Intravascular Large B Cell Lymphoma: An Elusive Cause of Pyrexia of Unknown Origin Diagnosed Postmortem. Holmes, N. E.; Gordon, C. L.; Lightfoot, N.; Crowley, P.; Buchanan, R. R.; Smith, C. L.; Johnson, P. D. R. // Clinical Infectious Diseases;11/1/2010, Vol. 51 Issue 9, pe61 

    Intravascular large B cell lymphoma (IVLBCL) is a rare cause of pyrexia of unknown origin. Because of its protean clinical manifestations, diagnosis is elusive and is often made postmortem. We report here a case of IVLBCL that evaded diagnosis despite multiple investigations in vivo for pyrexia...

  • Granulomatous Pneumocystis jiroveci Pneumonia in a Patient with Diffuse Large B-Cell Lymphoma: Case Report and Review of the Literature. Hung Chang; Lee-Yung Shih; Chi-Wei Wang; Wen-Yu Chuang; Chien-Cheng Chen // Acta Haematologica;Dec2009, Vol. 123 Issue 1, p30 

    Here we report a case of diffuse large B-cell lymphoma who developed granulomatous Pneumocystis jiroveci pneumonia (PJP) after rituximab and combination chemotherapy. The infection presented as a solitary pulmonary nodule (SPN) instead of the commonly seen diffuse ground-glass infiltrates. The...

  • Primary Ki-1-Positive T-Cell Lymphoma of the Brain in a Child. Buxton, N.; Punt, J.; Hewitt, M. // Pediatric Neurosurgery;Nov98, Vol. 29 Issue 5, p250 

    A unique case of a female child with primary Ki-1-positive T-cell lymphoma of the brain is reported. Her clinical course is discussed and the previous literature is reviewed.

  • Characteristics of Non-Hodgkin’s Lymphoma Complicated by Renal Cell Malignancies. Ohsawa, Masahiko; Hashimoto, Michiko; Yasunaga, Yutaka; Shingu, Norihisa; Aozasa, Katsuyuki // Oncology;1998, Vol. 55 Issue 5, p482 

    Previous epidemiological studies showed an increased risk for the development of renal cell carcinoma (RCC) after adjuvant therapy or simultaneous discovery of non-Hodgkin’s lymphoma (NHL). However, clinicopathological features of NHL complicated by RCC are not well known. We summarized...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics